MEDS establishes operations at Catena’s premises in Stockholm
Online pharmacy MEDS will be moving into one of Catena’s logistics properties at a strategic location in the Västberga industrial area in Stockholm.
14 September 2020, 08:30 a.m. CET
Catena has signed a seven-year lease with MEDS, a full-scale online pharmacy that sells prescription and over-the-counter drugs with a permit from the Swedish Medical Products Agency. MEDS will lease approximately 5,600 square metres of space in the Nattskiftet 11 property. The property, which accommodates several tenants, has been modernised and undergone major changes in recent years. These renovations exemplify how logistics properties are developed and can take on new functions as flows and purchasing patterns change.
“We look forward to a long-term partnership in which we provide functional premises for an exciting and growing e-commerce player in an excellent city logistics location. MEDS imposes rigorous demands on warehousing and logistics solutions, and we like that!” says Tobias Karlsson, Regional Manager for Catena in Stockholm.
“MEDS’ objective is to deliver customers’ orders as quickly, sustainably and smoothly as possible. Our new head office and logistics centre in Västberga provides optimum conditions for our expansion,” says Björn Thorngren, CEO of MEDS.
MEDS will move into its new premises at the end of 2020/beginning of 2021.
For further information, please contact
Tobias Karlsson, Regional Manager Stockholm, Tel. +46 (0)730-70 22 36,
Catena is a listed property company that, through collaboration sustainably develops, owns and manages efficient logistics facilities. Its strategically located properties supply the Scandinavian metropolitan areas and are adapted for both current and future goods flows. The overall objective is to generate strong cash flow, enabling stable development and providing shareholders a favourable total return in the long term. As of 30 June 2020, the properties had a total value of SEK 17,222.5 million. Catena’s shares are traded on NASDAQ Stockholm, Mid Cap.